Axsome Therapeutics Insider Trades

AXSM

Track insider trading activity from Axsome Therapeutics executives and directors. See which insiders are buying and selling AXSM stock.

Trades Last 12 Months

AXSM Price

All Insider Trades for Axsome Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Jacobson Mark L. Chief Operating Officer
Holding Value $1.36M 10,000 shares
Last Trade
Sep 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.08M 10,000 shares
$208.35
$136.01
Tabuteau Herriot 10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Aug 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$997k 4,660 shares
$213.95
$136.01
Jeffs Roger Director
Holding Value $7.94M 58,367 shares
Last Trade
Jun 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.2k 286 shares
$249.12
$136.01
Coleman Mark Director
Holding Value $4.13M 30,389 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$160k 643 shares
$249.00
$136.01
Mahony Susan Director
Holding Value $113k 829 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$73.9k 300 shares
$246.18
$136.01
Pizzie Nick Chief Financial Officer
Holding Value $9.79M 72,000 shares
Last Trade
Jun 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.11M 33,000 shares
$245.64
$136.01
Saad Mark E Director
Holding Value $1.55M 11,431 shares
Last Trade
Jun 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$336k 1,429 shares
$235.14
$136.01
Maizel Ari Chief Commercial Officer
Holding Value $1.02M 7,500 shares
Last Trade
Apr 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 7,500 shares
$186.42
$136.01
Murdock Hunter R. General Counsel
Holding Value $983k 7,224 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 7,224 shares
$182.97
$136.01
Tabuteau Herriot 10% owner, Chief Executive Officer
Holding Value $3.28M 24,081 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.41M 24,081 shares
$182.97
$136.01
Jeffs Roger Director
Holding Value $7.82M 57,510 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.67M 13,464 shares
$123.68
$136.01
Marek David C Chief Commercial Officer
Holding Value $7.34M 53,984 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 70,517 shares
$45.14
$136.01
Potter Myrtle S Director
Holding Value $1.77M 13,000 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 13,000 shares
$22.03
$136.01
Golubieski John Chief Financial Officer
Holding Value $18M 132,000 shares
Last Trade
Aug 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$779k 132,000 shares
$5.90
$136.01
Ames Constance Vice President, Finance
Holding Value $3.4M 25,000 shares
Last Trade
Mar 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 25,000 shares
$4.95
$136.01
Kaye Randall Chief Medical Officer
Holding Value $819k 6,022 shares
Last Trade
Dec 23, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.03k 1,000 shares
$9.03
$136.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up